Table 4.

Baseline characteristics for relapse outcomes on PP3M and PPLAI.

Characteristic	Total		PP3M no relapse		PP3M relapse		PPLAI no relapse		PPLAI relapse
	n = 186		n = 166		n = 20		n = 164		n = 22
Age on initiation of PP3M (years)
Mean, SD	45, 13.2		46, 12.8		40, 15.9		46, 12.8		40, 15.3
Min, max	20, 77		20, 77		22, 77		20, 77		22, 77
Prior duration of PP1M (months)
Mean, SD	34, 24.5		34, 24.6		33, 24.1		34, 24.6		35, 23.8
Min, max	3, 89		3, 89		4, 75		3, 89		4, 75

Abbreviations: PPLAI, paliperidone long-acting injection; PP1M, one monthly paliperidone; PP3M, Paliperidone 3-monthly; SD, standard deviation.

^aDiscontinuers includes those who stopped due to death or being lost to follow-up.